A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF00690180.pdf
Reference53 articles.
1. Early Breast Cancer Trialist's Colloborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1?15, 71-85, 1992
2. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884?2888, 1980
3. Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PP, Schwartz M: Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47: 2364?2367, 1981
4. Chevallier B, Meintzmann F, Mosseri Vet al.: Prognostic value of estrogen and progesterone receptors in operable breast cancer: results of a univariate and multivariate analysis. Cancer 62: 2517?2524, 1988
5. Hilf R, Feldstein ML, Savlov ED, Gibson SL, Seneca B: The lack of relationship between estrogen receptor status and response to chemotherapy. Cancer 46: 2797?2800, 1980
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer;Journal of Clinical Oncology;2023-03-01
2. Idade como fator independente de prognóstico no câncer de mama;Revista Brasileira de Ginecologia e Obstetrícia;2008-02
3. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas;Cytometry Part B: Clinical Cytometry;2005
4. Young age: an independent risk factor for disease-free survival in women with operable breast cancer;BMC Cancer;2004-11-17
5. A research on the level of urine neopterin to see if it may provide a vital clue for a provisional diagnosis of breast cancer in menopausal women;Maturitas;2004-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3